Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

N-(4-(1-cyanocyclopentyl)phenyl)-2-(4-pyridinylmethyl)amino-3-pyridinecarboxamide methanesulfonate

EU orphan designation number: EU/3/17/1840   
Active ingredient: N-(4-(1-cyanocyclopentyl)phenyl)-2-(4-pyridinylmethyl)amino-3-pyridinecarboxamide methanesulfonate
Indication: Treatment of gastric cancer
Sponsor: LSK Biopharma Limited
The Black Church, ST. Mary's Place, Dublin, D07 P4AX, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
1/03/2017 Orphan designation EMA/OD/228/16 (2017)1506 of 27/02/2017
14/02/2019 Transfer of orphan designation EMA/OD/0000003244 (2019)1347 of 12/02/2019